6137 search
Vertex Pharmaceuticals Incorporated
NASDAQ VRTX 490,32 US$ 20,50%
Logo

How to play weak Q2 earnings season: Analysts

Publié le 18 mai 2015

Pour voir l'article original, cliquez ici .

Les autres articles de la compagnie
What You Need To Know In Biotech: An ASCO Disappointment, Bi
Vertex Could Give Investors Vertigo
Gilead: No Big Deals
Vertex Pharmaceuticals (VRTX) Stock Climbs Following FDA Adv
Analyst: Patients were key to Vertex panel recommendation
Articles en illimité et contenus premium Je m'abonne
Editoriaux
et Nouvelles
Actions
Minières
Or et
Argent
Marchés La Cote
search 6137
search